Department of Urology

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the U.S.

Roger Dmochowski, MD, MMHC, professor of Urology, Surgery, and Obstetrics & Gynecology and director of the Section of Female Pelvic Medicine, has been promoted to Vice President and Executive Medical Director of Perioperative Services at Vanderbilt University Hospital. He will function full time in this role.

The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. 

Vanderbilt Urology’s newly renovated TVC clinic features a slightly larger and much more efficient space, nitrous oxide in the procedure rooms, a new high definition C-Arm X-ray machine and a urodynamics unit, thereby expanding the range of procedures that can be performed in clinic without having to go to the operating room.

Vanderbilt's Sam S. Chang, MD, has been elected trustee of the American Board of Urology, with a six-year term beginning March 21.

Joseph Smith Jr., MD, recent decision to step back from clinical practice is allowing him to focus entirely on global surgery efforts departmentally with faculty, fellows and residents to provide opportunities he believes are a key part of infusing humanitarian intent into their training.

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.